Types of Glaucoma and Optic Disc Damage Relationship with Prevalence of Glaucoma in Ezinihitte LGA

Bourne, R. R. A., Flaxman, S. R., Braithwaite, T., Cicinelli, M. V., Das, A., Jonas, J. B., … & Resnikoff, S. (2017). Global vision impairment and blindness due to glaucoma. Global Eye Health, 10(3), 1-7. Centers for Disease Control and Prevention (CDC). (2020). Glaucoma. Centers for Disease Control and Prevention. Glaucoma Research Foundation. (2023). What is glaucoma? Glaucoma Research Foundation. Jonas, J. B., Aung, T., & Bourne, R. R. A. (2020). Glaucoma. The Lancet, 396(10257), 1272- Kyari, F., Oluleye, T. S., & Eze, B. I. (2015). Glaucoma prevalence and risk factors in Nigeria. BMC Ophthalmology, 15, 1-6. Leske, M. C., Heijl, A., Hyman, L., Bengtsson, B., & Dong, L. (2003). Predictors of long- term progression in the Early Manifest Glaucoma Trial. Ophthalmology, 110(6), 1200-1206. Medeiros, F. A., & Weinreb, R. N. (2012). Normal-tension glaucoma: An overview. Journal of Glaucoma, 21(3), 129-135. Papadopoulos, M., Tsaousis, K., & Martinez, S. M. (2014). Developmental glaucoma: Etiology and management. Ophthalmic Genetics, 35(4), 267-272. Tham, Y. C., Li, X., Wong, T. Y., Quigley, H. A., Aung, T., & Cheng, C. Y. (2014). Global prevalence of glaucoma and projections of glaucoma burden through 2040: A systematic review and meta-analysis. Ophthalmology, 121(11 Weinreb, R. N., Aung, T., & Medeiros, F. A. (2023). The pathophysiology and management of glaucoma. The Lancet, 402(10371), 306-318.